Retatrutide is a new treatment in the fight against obesity. This revolutionary drug, categorized as a dual GLP-1 and GIP receptor agonist, shows promising results in clinical trials. By boosting these receptors, https://donnaqlro167045.spintheblog.com/36591528/tirzepatide-a-promising-new-treatment-for-obesity